Industry News
Lung Cancer Prevention Potential For Estrogen-Targeting Drug Combo
Jan 10, 2012
A combination of drugs that target estrogen production significantly reduced the number of tobacco carcinogen-induced lung tumors in mice, according to results from a preclinical study. "Antiestrogens have been shown to prevent breast cancer in some women," said Jill M. Siegfried, Ph.D... Read More
Indication Of Considerable Added Benefit From Abiraterone In Certain Prostate Cancer Patients
Jan 10, 2012
Advantages for men with metastatic hormone-refractory prostate cancer who are no longer eligible for docetaxel therapy Abiraterone (trade name: Zytiga®) has been approved since September 2011 for men with metastatic prostate cancer that is no longer responsive to hormone therapy and progresses further during or after therapy with the cytostatic drug docetaxel... Read More
Smokers Taking Statins May Be At Increased Risk Of Interstitial Lung Abnormalities
Jan 10, 2012
Use of statins may influence susceptibility to or the progression of interstitial lung disease (ILD) in smokers, according to a new study... Read More
Researchers Find Malignancy-Risk Gene Signature For Early-Stage Non-Small Cell Lung Cancer
Jan 10, 2012
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute... Read More
Newcastle Scientists Find Genetic Key To Why Some Cancer Patients Don't Respond To Treatment
Jan 09, 2012
In a study funded by the charity Leukemia & Lymphoma Research published in the leukemia journal Blood in January, scientists from Newcastle University have discovered a gene variation that occurs in 20% of the population, which can have a substantial effect on treatment responses in patients with a rare type of blood cancer... Read More
Lithocholic Acid Kills Cancer Cells But Not Healthy Cells
Jan 09, 2012
The abilities of an acid that is naturally produced in the liver during digestion, called Lithocholic acid (LCA) have seriously been underestimated until now. According to a study led by Concordia University published in Oncotarget, LCA can kill several types of cancer cells, including those found in some brain tumors and breast cancer... Read More
Test All Hospitalized Patients For Blood Glucose Levels, Experts Say
Jan 09, 2012
Hyperglycemia, or high blood sugar (glucose) levels, is a common, serious and expensive health care problem in hospitalized patients that is linked to an increased risk of health complications and mortality. It can also affect non-diabetic hospitalized patients. According to observational studies, 32 to 38% of patients in community hospitals suffer from hyperglycemia... Read More
Yearly Prostate Cancer Screening Does Not Lower Total Number Of Deaths
Jan 09, 2012
Mass prostate cancer screenings do not lower total number of deaths from prostate cancer, researchers from Washington University School of Medicine at St. Louis reported in the Journal of the National Cancer Institute. They added that mass routine screenings do not even reduce numbers of deaths among males in their fifties and sixties, as well as patients with underlying health conditions... Read More
Fibroblasts Contribute To Melanoma Tumor Growth, Say Moffitt Cancer Center Researchers
Jan 09, 2012
Fibroblasts, cells that play a role in the structural framework of tissues, play an apparent role in melanoma tumor growth. Fibroblasts also contribute to melanoma drug resistance and may also facilitate the "flare" response when a tumor's metabolism is enhanced following a patient being removed from a targeted therapy, said researchers at Moffitt Cancer Center in Tampa, Fla. Alexander R... Read More
Study Finds Tobacco Company Misrepresented Danger From Cigarettes; Toxicity Levels Obscured, Increasing Risks Of Heart Disease, Cancer
Jan 09, 2012
A new UCSF analysis of tobacco industry documents shows that Philip Morris USA manipulated data on the effects of additives in cigarettes, including menthol, obscuring actual toxicity levels and increasing the risk of heart, cancer and other diseases for smokers. Tobacco industry information can't be taken at face value, the researchers conclude... Read More
Previous Page Next Page